Biochemical Pharmacology 1987-10-15

Dibenzoquinazoline diones as antihypertensive cyclic guanosine monophosphate phosphodiesterase inhibitors.

R F Booth, S P Buckham, D O Lunt, P W Manley, R A Porter

Index: Biochem. Pharmacol. 36(20) , 3517-21, (1987)

Full Text: HTML

Abstract

The discovery and structure-activity of a new class of renal artery phosphodiesterase inhibitors is reported, some of which are highly selective for the guanosine cyclic 3',5'-monophosphate phosphodiesterase. One of these compounds, 5,6-dihydro-8,9,11,12-tetramethoxy-1,3-dioxo-1H-benz[f]- isoquino [8,1,2- hij]quinazoline-2(3H)-carboxylic acid, ethyl ester (9), is amongst the most potent and selective compounds of this class yet identified. Furthermore, this compound demonstrates an antihypertensive effect in vivo which is presumably mediated through vascular smooth muscle relaxation.

Related Compounds

Related Articles:

Pituitary adenylate cyclase activating polypeptide (PACAP) potently enhances tyrosine hydroxylase (TH) expression in adrenal chromaffin cells.

1994-01-01

[Life Sci. 54(22) , 1735-43, (1994)]

Atrial natriuretic peptide reduces cyclic AMP by activating cyclic GMP-stimulated phosphodiesterase in vascular endothelial cells.

1994-09-01

[J. Cardiovasc. Pharmacol. 24(3) , 351-7, (1994)]

Role of cGMP-inhibited phosphodiesterase and sarcoplasmic calcium in mediating the increase in basal heart rate with nitric oxide donors.

2000-10-01

[J. Mol. Cell. Cardiol. 32(10) , 1831-40, (2000)]

Effects of colforsin, trequinsin and isoprenaline on norepinephrine-induced contractions and cyclic nucleotide levels of isolated vascular tissue.

1988-02-01

[Arzneimittelforschung 38(2) , 240-3, (1988)]

Dissociation between phosphodiesterase inhibition and antiproliferative effects of phosphodiesterase inhibitors on the Dami cell line.

1997-04-25

[Biochem. Pharmacol. 53(8) , 1141-7, (1997)]

More Articles...